European Healthtech startup funding raised during H2 2026.
H2 2026 is in progress (through 2026-10-07): 92 European Healthtech companies have raised €2.0B across 93 funding rounds so far. Sweden leads by capital raised, and European Investment Bank (EIB) is the most active investor. Data as of 7 Oct 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Neko Health | Series C | Jul 2026 | €614M |
| Basecamp Research | Series C | Sep 2026 | €123M |
| Scan.com | Debt | Sep 2026 | €112M |
| Elekta | Debt | Aug 2026 |
4 exits.
| €100M |
| HighLife | Other | Sep 2026 | €80M |
| Scan.com | Other | Sep 2026 | €78M |
| Breye Therapeutics | Series A | Oct 2026 | €68M |
| AnaCardio | Series B | Sep 2026 | €63M |
| Anaconda Biomed | Other | Sep 2026 | €49M |
| Mironid | Series B | Aug 2026 | €40M |
| Aptadir Therapeutics | Seed | Sep 2026 | €40M |
| Implicity | Growth/Late | Sep 2026 | €35M |
| Adaptyv Biosystems | Series A | Aug 2026 | €34M |
| Biolevate | Series A | Sep 2026 | €30M |
| Ethris | Other | Sep 2026 | €30M |